These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 12368200
1. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis. Cook HT, Khan SB, Allen A, Bhangal G, Smith J, Lobb RR, Pusey CD. Am J Pathol; 2002 Oct; 161(4):1265-72. PubMed ID: 12368200 [Abstract] [Full Text] [Related]
8. Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis. Han Y, Ma FY, Tesch GH, Manthey CL, Nikolic-Paterson DJ. Am J Physiol Renal Physiol; 2013 Apr 15; 304(8):F1043-53. PubMed ID: 23408165 [Abstract] [Full Text] [Related]
9. Myofibroblasts and the progression of experimental glomerulonephritis. Zhang G, Moorhead PJ, el Nahas AM. Exp Nephrol; 1995 Apr 15; 3(5):308-18. PubMed ID: 7583053 [Abstract] [Full Text] [Related]
13. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis. Kinoshita Y, Kondo S, Urushihara M, Suga K, Matsuura S, Takamatsu M, Shimizu M, Nishiyama A, Kawachi H, Kagami S. Transl Res; 2011 Oct 01; 158(4):235-48. PubMed ID: 21925120 [Abstract] [Full Text] [Related]
20. Decrease in cell proliferation by an matrix metalloproteinase inhibitor, doxycycline, in a model of immune-complex nephritis. Saglam F, Celik A, Tayfur D, Cavdar Z, Yilmaz O, Sarioglu S, Kolatan E, Oktay G, Camsari T. Nephrology (Carlton); 2010 Aug 01; 15(5):560-7. PubMed ID: 20649877 [Abstract] [Full Text] [Related] Page: [Next] [New Search]